XML 35 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share
12 Months Ended
Mar. 28, 2021
Earnings Per Share  
Earnings Per Share

Note 14. Earnings Per Share

The Company presents the computation of earnings per share (“EPS”) on a basic and diluted basis. Basic EPS is computed by dividing net income by the weighted average number of shares outstanding during the reported period. Diluted earnings per share are computed similarly to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential additional common shares that were dilutive had been issued. Shares of common stock are excluded from the calculation if they are determined to be anti-dilutive. In fiscal years 2021 and 2020, the Company had a net loss and accordingly recorded EPS by using only basic shares outstanding.

The following table presents the calculation of basic and diluted earnings per common share from continuing operations:

 

Amounts in thousands, except per share amounts

Amounts in thousands, except per share amounts

 

2021

2020

 

2019

Earnings per share from continuing operations – Basic:

    

    

    

    

Net loss

$

(14,373)

$

(15,601)

$

(8,882)

Weighted average common shares outstanding – Basic

 

8,697

 

8,527

 

8,437

Earnings per common share from continuing operations – Basic

$

(1.65)

$

(1.83)

$

(1.05)

Earnings per share – Diluted:

Net loss

$

(14,373)

$

(15,601)

$

(8,882)

Weighted average common shares outstanding – Basic

 

8,697

 

8,527

 

8,437

Effect of dilutive options

 

 

 

Weighted average common shares outstanding – Diluted

 

8,697

 

8,527

 

8,437

Loss per common share from continuing operations – Diluted

$

(1.65)

$

(1.83)

$

(1.05)

Anti-dilutive equity awards not included above

 

755

 

852

 

94

At March 28, 2021, March 29, 2020, and March 31, 2019 stock options with respect to 925,000, 862,000 and 591,500 shares of common stock were outstanding, respectively. The anti-dilutive stock options outstanding at March 28, 2021, March 29, 2020, and March 31, 2019 total 755,000, 852,000 and 94,000, respectively.  There were no anti-dilutive Performance Stock Units or Restricted Stock Units outstanding as of March 28, 2021, March 29, 2020, and March 31, 2019.